Setmelanotide is an effective medication for the disease of obesity in patients older than 6 years if the patient has POMC deficiency, PCSK1 deficiency, LEPR deficiency, or Bardet–Biedl syndrome [21,38,39,40]. The gene discussed is LEPR; the disease is obesity due to melanocortin 4 receptor deficiency.